Siedlar M - Search Results

1

TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells.

Rolski F, Tkacz K, Węglarczyk K, Kwiatkowski G, Pelczar P, Jaźwa-Kusior A, Bar A, Kuster GM, Chłopicki S, Siedlar M, Kania G, Błyszczuk P. Rolski F, et al. Among authors: siedlar m. Cardiovasc Res. 2024 Feb 27;120(1):82-94. doi: 10.1093/cvr/cvad158. Cardiovasc Res. 2024. PMID: 37879102 Free PMC article.

2

Preoperative endoscopic intratumor application of tumor necrosis factor alpha in patients with locally advanced resectable gastric cancer.

Karcz D, Popiela T, Szczepanik AM, Czupryna A, Szymanska B, Siedlar M, Zembala M. Karcz D, et al. Among authors: siedlar m. Endoscopy. 1994 May;26(4):369-70. doi: 10.1055/s-2007-1008998. Endoscopy. 1994. PMID: 8076575 Clinical Trial. No abstract available.

3

[Clinical probes using tumor necrosis factor in treatment of neoplastic diseases].

Szczepanik A, Tabor J, Siedlar M. Szczepanik A, et al. Among authors: siedlar m. Przegl Lek. 1994;51(11):497-500. Przegl Lek. 1994. PMID: 7871196 Review. Polish.

4

Demonstration of iNOS-mRNA and iNOS in human monocytes stimulated with cancer cells in vitro.

Siedlar M, Mytar B, Krzeszowiak A, Baran J, Hyszko M, Ruggiero I, Wieckiewicz J, Stachura J, Zembala M. Siedlar M, et al. J Leukoc Biol. 1999 May;65(5):597-604. doi: 10.1002/jlb.65.5.597. J Leukoc Biol. 1999. PMID: 10331487

5

Commentary to the letter of Tjon et al.

Siedlar M, Ziegler-Heitbrock L. Siedlar M, et al. Clin Immunol. 2012 Nov;145(2):141. doi: 10.1016/j.clim.2012.09.005. Epub 2012 Sep 20. Clin Immunol. 2012. PMID: 23041503 No abstract available.

6

[Reccurent mycobacterial diseases in patients with impaired axis IL-12/INF-gamma].

Strach M, Nalepa P, Sulicka-Grodzicka J, Kierzkowska I, Siedlar M, Grodzicki T. Strach M, et al. Among authors: siedlar m. Przegl Lek. 2013;70(12):1058-60. Przegl Lek. 2013. PMID: 24720128 Review. Polish.

7

Pentoxifylline does not affect nociception if administered postoperatively.

Szczepanik AM, Wordliczek J, Serednicki W, Siedlar M, Czupryna A. Szczepanik AM, et al. Among authors: siedlar m. Pol J Pharmacol. 2004 Sep-Oct;56(5):611-6. Pol J Pharmacol. 2004. PMID: 15591651 Free article. Clinical Trial.

8

The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation.

Kroczak TJ, Baran J, Pryjma J, Siedlar M, Reshedi I, Hernandez E, Alberti E, Maddika S, Los M. Kroczak TJ, et al. Among authors: siedlar m. Expert Opin Ther Targets. 2006 Apr;10(2):289-302. doi: 10.1517/14728222.10.2.289. Expert Opin Ther Targets. 2006. PMID: 16548777 Free article. Review.

9

Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.

Den Otter W, Dobrowolski Z, Bugajski A, Papla B, Van Der Meijden AP, Koten JW, Boon TA, Siedlar M, Zembala M. Den Otter W, et al. Among authors: siedlar m. J Urol. 1998 Apr;159(4):1183-6. doi: 10.1097/00005392-199804000-00021. J Urol. 1998. PMID: 9507828 Clinical Trial.

10

Antitumor response of CD14+/CD16+ monocyte subpopulation.

Szaflarska A, Baj-Krzyworzeka M, Siedlar M, Weglarczyk K, Ruggiero I, Hajto B, Zembala M. Szaflarska A, et al. Among authors: siedlar m. Exp Hematol. 2004 Aug;32(8):748-55. doi: 10.1016/j.exphem.2004.05.027. Exp Hematol. 2004. PMID: 15308326 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page